148 related articles for article (PubMed ID: 33747363)
1. Quantitative proteome profiling stratifies fibroepithelial lesions of the breast.
Kumar A; Nayakanti DS; Mangalaparthi KK; Gopinath V; Reddy NVN; Govindan K; Voolapalli G; Kumar P; Kumar LD
Oncotarget; 2021 Mar; 12(5):507-518. PubMed ID: 33747363
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract][Full Text] [Related]
4. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
5. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
6. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
7. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
[TBL] [Abstract][Full Text] [Related]
8. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract][Full Text] [Related]
9. Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.
Piscuoglio S; Geyer FC; Burke KA; Murray MP; Ng CK; Mota A; Marchio C; Berman SH; Norton L; Brogi E; Weigelt B; Reis-Filho JS
NPJ Breast Cancer; 2016; 2():16035. PubMed ID: 28721388
[TBL] [Abstract][Full Text] [Related]
10. Phyllodes Tumors of the Breast: A Literature Review.
Rayzah M
Cureus; 2020 Sep; 12(9):e10288. PubMed ID: 32923300
[TBL] [Abstract][Full Text] [Related]
11. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
12. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
13. Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms.
Yang X; Kandil D; Cosar EF; Khan A
Arch Pathol Lab Med; 2014 Jan; 138(1):25-36. PubMed ID: 24377809
[TBL] [Abstract][Full Text] [Related]
14. Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor.
Van Osdol AD; Landercasper J; Andersen JJ; Ellis RL; Gensch EM; Johnson JM; De Maiffe B; Marcou KA; Al-Hamadani M; Vang CA
JAMA Surg; 2014 Oct; 149(10):1081-5. PubMed ID: 25162470
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
16. Audit of fibroepithelial tumors of the breast in a Nigerian tertiary institution.
Daramola AO; Oguntunde OA; Awolola NA
Niger J Clin Pract; 2016; 19(5):645-8. PubMed ID: 27538554
[TBL] [Abstract][Full Text] [Related]
17. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract][Full Text] [Related]
18. Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?
Limberg J; Barker K; Hoda S; Simmons R; Michaels A; Marti JL
World J Surg; 2020 May; 44(5):1552-1558. PubMed ID: 31974650
[TBL] [Abstract][Full Text] [Related]
19. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
20. Versican core protein aids in the diagnosis and grading of breast phyllodes tumor.
Zhang L; Bi J; Yu X; Li X; Liu X; Weng X; Shao M
Ann Diagn Pathol; 2023 Oct; 66():152176. PubMed ID: 37423116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]